spacer
home > pmps > summer 2017 > serialisation software
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Serialisation Software

The Falsified Medicines Directive (FMD) deadline of February 2019 is fast approaching for European pharmaceutical manufacturers and their supply chain partners. As the EU Intellectual Property Office discovered in a 2016 study, fake medicines cost the EU pharma industry more than €10 billion in lost revenue and nearly 38,000 lost jobs every year (1). The FMD-mandated measures – which include a unique identifier code and tamper-evident packaging for pharma products – will protect supply chains and help cut down on these losses.

More importantly, the new law provides health and safety benefits. While no definitive findings on the human toll of falsified drugs exist, they are believed to be responsible for 100,000 to 1,000,000 deaths every year, worldwide. Although compliance with FMD is undeniably important, it should not be the only factor driving pharma companies’ serialisation decisions and actions.

Additionally, as more firms integrate Internet of Things technologies into their production and business processes, serialisation presents an opportunity to collect data to create smarter, more efficient supply chains. Pharma manufacturers are realising that they can get a return on their compliance investment by capturing serialisation data and turning them into valuable insights that enhance business operations. Because of this, companies and their partners should be mindful when evaluating and implementing serialisation software to boost visibility, productivity and business optimisation.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Michael Howe is Chief Executive Officer at Verify Brand. As a pioneer in creating disruptive innovations, he leverages his decades of experience with Fortune 100 companies and other leading brands to help pharma organisations integrate serialisation technology to drive business growth.
spacer
Michael Howe
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Charles River Laboratories Expands Services for Early Discovery Screening

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the expansion of its service capabilities in early discovery screening. Charles River is the first contract research organization to offer clients access to Apricot Designs' Dual Arm (ADDA) system for high-throughput absorption, distribution, metabolism, and excretion (HT-ADME) to identify potential lead compounds in North America and Europe. Additionally, the Company has geographically expanded its pharmacokinetic (PK) capabilities at sites central to major pharmaceutical and biotechnology hubs.
More info >>

White Papers

Finding the Right End-to-End Safety Solution for Your Needs

Bioclinica

With upcoming changes, including the implementation of the International Conference on Harmonisation (ICH) E2B(R3) Electronic Transmission of Individual Case Safety Report and Identification of Medicinal Products (IDMP) standards, the current state of safety reporting can be confusing. Your existing safety system may not be flexible enough to accommodate these changing regulations, which are still moving targets regarding the details needed for a comprehensive solution with the right level of processes, company-to-company integrations and finalized regional rules.
More info >>

 
Industry Events

DIA 2018 Global Annual Meeting

24-28 June 2018, Boston, MA

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe. Designed to drive insights into action by connecting key policy discussions to real-world knowledge that you need to do your job every day, your attendance will accelerate your growth and your organization's performance in the development ecosystem.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement